- alpha-methyldopamine (α-Me-DA)), 3,4-methylenedioxyphenylacetone (MDP2P), and 3,4-
methylenedioxy-N-hydroxyamphetamine (MDOH). The
contributions of
these metabolites...
-
Methylenedioxy is the term used in the
field of chemistry,
particularly in
organic chemistry, for a
functional group with the
structural formula R−O−CH2−O−R'...
- (MDA), 3,4-
methylenedioxy-N-ethylamphetamine (MDEA; "Eve"), N-methyl-1,3-benzodioxolylbutanamine (MBDB; "Eden"), and 3,4-
methylenedioxy-N-methylcathinone...
-
metabolism of
safrole through the
oxidation of the
methylenedioxy proceeds via the
cleavage of the
methylenedioxy group. This
results in two
major metabolites:...
- 3,4-
Methylenedioxy-N-ethylamphetamine (MDEA; also
called MDE and colloquially, Eve) is an
empathogenic psychoactive drug. MDEA is a
substituted amphetamine...
- 3,4-
Methylenedioxy-N-hydroxy-N-methylamphetamine (MDHMA; FLEA) is an entactogen, psychedelic, and
stimulant of the
phenethylamine and
amphetamine chemical...
-
substituted with a
methylenedioxy functional group. It is
commonly synthesized from
either safrole (which, for comparison, is 3-[3,4-(
methylenedioxy)phenyl]-2-propene)...
- 3',4'-
Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a
stimulant designer drug. It was sold in
Germany in the late 1990s and
early 2000s as an ingredient...
- 3,4-
Methylenedioxy-N,N,N-trimethylamphetamine (MDTMA) is a
chemical compound of the
amphetamine and
methylenedioxyamphetamine families. In
contrast to...
- 6,7-
Methylenedioxy-2-aminotetralin (MDAT) is a drug
developed in the 1990s by a team at
Purdue University led by
David E. Nichols. It
appears to act as...